HK1139064A1 - Therapeutic agent for meniere's disease - Google Patents

Therapeutic agent for meniere's disease

Info

Publication number
HK1139064A1
HK1139064A1 HK10105173.6A HK10105173A HK1139064A1 HK 1139064 A1 HK1139064 A1 HK 1139064A1 HK 10105173 A HK10105173 A HK 10105173A HK 1139064 A1 HK1139064 A1 HK 1139064A1
Authority
HK
Hong Kong
Prior art keywords
meniere
disease
therapeutic agent
therapeutic
agent
Prior art date
Application number
HK10105173.6A
Other languages
English (en)
Inventor
Setsuko Takeda
Original Assignee
Setsuko Takeda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Setsuko Takeda filed Critical Setsuko Takeda
Publication of HK1139064A1 publication Critical patent/HK1139064A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/729—Agar; Agarose; Agaropectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK10105173.6A 2007-01-10 2010-05-26 Therapeutic agent for meniere's disease HK1139064A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2007/050172 WO2008084533A1 (ja) 2007-01-10 2007-01-10 メニエール病治療薬

Publications (1)

Publication Number Publication Date
HK1139064A1 true HK1139064A1 (en) 2010-09-10

Family

ID=39608438

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105173.6A HK1139064A1 (en) 2007-01-10 2010-05-26 Therapeutic agent for meniere's disease

Country Status (6)

Country Link
US (1) US8445461B2 (ko)
EP (1) EP2127658A4 (ko)
KR (1) KR101406231B1 (ko)
CN (1) CN101626771B (ko)
HK (1) HK1139064A1 (ko)
WO (1) WO2008084533A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009116490A1 (ja) * 2008-03-21 2009-09-24 Takeda Setsuko メニエール病治療薬
CN105727045A (zh) * 2016-04-15 2016-07-06 宁波优美科新材料有限公司 一种用于治疗梅尼埃病的药物
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816298A (en) * 1987-11-27 1989-03-28 The Dow Chemical Company Method of making a granular, cold water dispersible coating composition
JP2508555B2 (ja) * 1991-05-24 1996-06-19 株式会社紀文食品 苦味低減方法
EP0655461B1 (en) * 1993-11-16 2000-06-07 Novartis AG Cyclic amino acid derivatives having ACE and NEP inhibiting activity
AU3750495A (en) * 1994-10-28 1996-05-23 Innovative Technologies Limited Dehydrated hydrogels
US5656284A (en) * 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
JPH11180863A (ja) * 1997-10-16 1999-07-06 Nikken Chem Co Ltd メニエ−ル病治療薬
JPH11180803A (ja) 1997-12-19 1999-07-06 Sanyo Kako Kk 工業用殺菌・静菌安定化製剤とその製法
FR2775598A1 (fr) 1998-03-06 1999-09-10 Sanofi Sa Compositions pharmaceutiques contenant en association un antagoniste selectif des recepteurs v1a de l'arginine-vasopressine et un antagoniste selectif des recepteur v2 de l'arginine-vasopressine
JP2001226293A (ja) * 2000-02-17 2001-08-21 Kotaro Kanpo Seiyaku Kk 服用補助剤
JP4264105B2 (ja) * 2004-06-24 2009-05-13 株式会社三和化学研究所 イソソルビド含有ゼリー製剤
JP3947796B2 (ja) * 2005-06-21 2007-07-25 節子 竹田 メニエール病治療薬
JP4105732B2 (ja) 2006-03-01 2008-06-25 節子 竹田 メニエール病治療薬
JP4167283B2 (ja) 2006-09-28 2008-10-15 節子 竹田 甘味料
CN101164544A (zh) 2006-10-19 2008-04-23 云南白药集团股份有限公司 用于静脉滴注的豆腐果苷粉针剂及制备方法
JP4071818B1 (ja) 2007-01-10 2008-04-02 節子 竹田 甘味料
JP4122371B1 (ja) 2007-01-10 2008-07-23 節子 竹田 メニエール病治療薬
JP4113242B1 (ja) 2007-01-10 2008-07-09 節子 竹田 消化器症状の防止剤
JP4081131B1 (ja) 2007-01-10 2008-04-23 節子 竹田 メニエール病治療薬
JP4311453B2 (ja) 2007-01-26 2009-08-12 ソニー株式会社 レーザ光源装置及びこれを用いた画像生成装置
JP5101911B2 (ja) 2007-03-20 2012-12-19 パナソニック株式会社 ドレン蓋
JP5356655B2 (ja) 2007-03-20 2013-12-04 パナソニック株式会社 集水ます蓋
WO2009116490A1 (ja) 2008-03-21 2009-09-24 Takeda Setsuko メニエール病治療薬

Also Published As

Publication number Publication date
KR101406231B1 (ko) 2014-06-12
CN101626771A (zh) 2010-01-13
US8445461B2 (en) 2013-05-21
KR20100014346A (ko) 2010-02-10
EP2127658A4 (en) 2011-04-27
WO2008084533A1 (ja) 2008-07-17
CN101626771B (zh) 2012-11-14
US20100120712A1 (en) 2010-05-13
EP2127658A1 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
EP2119444A4 (en) THERAPEUTIC AGENT FOR PAIN
HK1124534A1 (en) Therapeutic agent for heart disease
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
EP2117311A4 (en) THERAPEUTICS
GB0601962D0 (en) Therapeutic agents
HRP20130041T8 (en) Therapeutic agents
GB0616214D0 (en) Therapeutic Agents
EP2133083A4 (en) THERAPEUTIC FOR SKIN OR MOLECULE INFECTIONS
GB0723747D0 (en) Therapeutic agents
GB0611152D0 (en) Therapeutic agents
GB0620818D0 (en) Therapeutic agents
GB0620059D0 (en) Therapeutic agents
GB0609676D0 (en) Therapeutic agents
HK1139064A1 (en) Therapeutic agent for meniere's disease
GB0701456D0 (en) Treatment for respiratory disease
EP1806137A4 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF GLOMERULAR DISEASE
EP2305629A4 (en) THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
PL1876175T3 (pl) Środek terapeutyczny do leczenia chorób rogówki
EP1859795A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
GB2447884B (en) Treatment for skin disease
EP1908467A4 (en) HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN
EP2210878A4 (en) THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES
EP1900363A4 (en) THERAPEUTIC AGENT AGAINST PAIN
GB0622195D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170110